ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

Obama Executive Order Gives FDA Authority To Combat Drug Shortages

November 4, 2011

In Brief: Transition Team Denies It Is Seeking New NCI Director; Garb Undergoes Surgery At M.D.A

November 28, 1980

FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate

August 14, 1992

CTEP Analyses Proposals For Changes In Cooperative Groups

April 25, 1986

NCAB Subcommittee Likes Organ Site Program, Except Smoking-Health

April 30, 1976

NCI, IOM Called To Congress to Explain Divergent Positions On Minority Research

January 29, 1999